NorthStar Asset Management (Pennsylvania)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$386K Sell
4,450
-300
-6% -$28.7K 0.09% 109
2025
Q4
$456K Hold
4,750
0.1% 101
2025
Q3
$452K Sell
4,750
-160
-3% -$14.7K 0.1% 101
2025
Q2
$428K Hold
4,910
0.1% 107
2025
Q1
$441K Sell
4,910
-905
-16% -$81K 0.11% 100
2024
Q4
$465K Sell
5,815
-250
-4% -$21.6K 0.11% 96
2024
Q3
$546K Sell
6,065
-3,710
-38% -$312K 0.13% 86
2024
Q2
$769K Sell
9,775
-210
-2% -$17.2K 0.19% 72
2024
Q1
$870K Buy
9,985
+160
+2% +$13.7K 0.21% 69
2023
Q4
$809K Sell
9,825
-1,477
-13% -$113K 0.21% 71
2023
Q3
$886K Sell
11,302
-225
-2% -$18.8K 0.26% 68
2023
Q2
$1.02M Sell
11,527
-300
-3% -$25.8K 0.28% 65
2023
Q1
$953K Sell
11,827
-930
-7% -$75.8K 0.28% 67
2022
Q4
$991K Sell
12,757
-175
-1% -$14.2K 0.31% 60
2022
Q3
$1.04M Sell
12,932
-755
-6% -$67.8K 0.35% 59
2022
Q2
$1.23M Sell
13,687
-462
-3% -$46.8K 0.38% 60
2022
Q1
$1.57M Sell
14,149
-273
-2% -$28.8K 0.4% 57
2021
Q4
$1.49M Sell
14,422
-1
-0% -$116 0.35% 60
2021
Q3
$1.81M Hold
14,423
0.47% 53
2021
Q2
$1.79M Sell
14,423
-350
-2% -$43.9K 0.47% 55
2021
Q1
$1.75M Buy
14,773
+250
+2% +$29.3K 0.5% 56
2020
Q4
$1.7M Sell
14,523
-77
-0.5% -$8.48K 0.48% 51
2020
Q3
$1.52M Buy
14,600
+100
+0.7% +$10K 0.48% 50
2020
Q2
$1.33M Hold
14,500
0.48% 48
2020
Q1
$1.31M Buy
14,500
+1,790
+14% +$190K 0.6% 43
2019
Q4
$1.44M Sell
12,710
-766
-6% -$84.1K 0.54% 50
2019
Q3
$1.46M Buy
13,476
+275
+2% +$28.7K 0.57% 49
2019
Q2
$1.29M Hold
13,201
0.51% 53
2019
Q1
$1.2M Hold
13,201
0.49% 53
2018
Q4
$1.2M Sell
13,201
-275
-2% -$25.7K 0.56% 49
2018
Q3
$1.32M Buy
13,476
+60
+0.4% +$5.55K 0.52% 51
2018
Q2
$1.15M Sell
13,416
-7,350
-35% -$614K 0.48% 53
2018
Q1
$1.67M Sell
20,766
-1,300
-6% -$107K 0.7% 39
2017
Q4
$1.78M Sell
22,066
-700
-3% -$56.1K 0.74% 40
2017
Q3
$1.77M Sell
22,766
-300
-1% -$24.9K 0.78% 39
2017
Q2
$2.05M Sell
23,066
-225
-1% -$19K 0.92% 32
2017
Q1
$1.88M Sell
23,291
-2,700
-10% -$211K 0.84% 36
2016
Q4
$1.85M Sell
25,991
-3,645
-12% -$286K 0.84% 37
2016
Q3
$2.56M Sell
29,636
-400
-1% -$34.9K 1.07% 30
2016
Q2
$2.61M Buy
30,036
+200
+0.7% +$16.2K 1.09% 30
2016
Q1
$2.24M Buy
29,836
+23,310
+357% +$1.76M 0.95% 34
2015
Q4
$502K Hold
6,526
0.21% 75
2015
Q3
$437K Hold
6,526
0.2% 80
2015
Q2
$484K Buy
6,526
+700
+12% +$53.5K 0.2% 79
2015
Q1
$454K Sell
5,826
-700
-11% -$53.1K 0.19% 81
2014
Q4
$471K Hold
6,526
0.2% 80
2014
Q3
$404K Hold
6,526
0.18% 83
2014
Q2
$416K Hold
6,526
0.18% 81
2014
Q1
$402K Hold
6,526
0.18% 75
2013
Q4
$375K Hold
6,526
0.17% 70
2013
Q3
$348K Hold
6,526
0.18% 69
2013
Q2
$336K Buy
+6,526
New +$323K 0.14% 79

Other funds holding MDT

NorthStar Asset Management (Pennsylvania)'s MDT Position: Q1 2026 in Review

NorthStar Asset Management (Pennsylvania) reduced its Medtronic (MDT) stake by 6.3% in Q1 2026, selling an estimated $28.7K and leaving 4,450 shares worth $386K. The position accounts for 0.09% of the portfolio, ranked #109.

NorthStar Asset Management (Pennsylvania) first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.61M in Q2 2016. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • NorthStar Asset Management (Pennsylvania) held 4,450 shares of Medtronic worth $386K as of Q1 2026.
  • NorthStar Asset Management (Pennsylvania) sold 300 Medtronic shares in Q1 2026, an estimated $28.7K.
  • Medtronic made up 0.09% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q1 2026, its #109 holding.
  • NorthStar Asset Management (Pennsylvania) first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • NorthStar Asset Management (Pennsylvania)'s Medtronic position peaked at $2.61M in Q2 2016.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2026, filed 23 Apr 2026.